354 related articles for article (PubMed ID: 25125424)
1. Lower urinary tract symptoms in men.
Hollingsworth JM; Wilt TJ
BMJ; 2014 Aug; 349():g4474. PubMed ID: 25125424
[TBL] [Abstract][Full Text] [Related]
2. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
Dahm P; Brasure M; MacDonald R; Olson CM; Nelson VA; Fink HA; Rwabasonga B; Risk MC; Wilt TJ
Eur Urol; 2017 Apr; 71(4):570-581. PubMed ID: 27717522
[TBL] [Abstract][Full Text] [Related]
5. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
6. Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
Strope SA; Vetter J; Elliott S; Andriole GL; Olsen MA
Urology; 2015 Dec; 86(6):1115-22. PubMed ID: 26375848
[TBL] [Abstract][Full Text] [Related]
7. BPH update: medical versus interventional management.
Blankstein U; Van Asseldonk B; Elterman DS
Can J Urol; 2016 Feb; 23(Suppl 1):10-5. PubMed ID: 26924590
[TBL] [Abstract][Full Text] [Related]
8. Management of Benign Prostatic Hyperplasia.
Kim EH; Larson JA; Andriole GL
Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
[TBL] [Abstract][Full Text] [Related]
9. Management of Benign Prostatic Hyperplasia in Older Adults.
Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
[TBL] [Abstract][Full Text] [Related]
10. [Management of benign prostate syndrome].
Herlemann A; Strittmatter F; Stief CG; Gratzke C
MMW Fortschr Med; 2013 Aug; 155(14):39-42. PubMed ID: 24006594
[No Abstract] [Full Text] [Related]
11. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
[TBL] [Abstract][Full Text] [Related]
12. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
[TBL] [Abstract][Full Text] [Related]
13. Treatment of benign prostatic hyperplasia.
Pinheiro LC; Martins Pisco J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
[TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
De Nunzio C; Tubaro A
Nat Rev Urol; 2015 Feb; 12(2):76-8. PubMed ID: 25558836
[No Abstract] [Full Text] [Related]
15. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
16. National Trends in the Management of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
Mahon JT; Welliver C
Curr Urol Rep; 2020 Nov; 21(12):63. PubMed ID: 33210174
[TBL] [Abstract][Full Text] [Related]
17. Impact of medical therapy on transurethral resection of the prostate: two decades of change.
Izard J; Nickel JC
BJU Int; 2011 Jul; 108(1):89-93. PubMed ID: 20883490
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Alcaraz A; Carballido-Rodríguez J; Unda-Urzaiz M; Medina-López R; Ruiz-Cerdá JL; Rodríguez-Rubio F; García-Rojo D; Brenes-Bermúdez FJ; Cózar-Olmo JM; Baena-González V; Manasanch J
Int Urol Nephrol; 2016 May; 48(5):645-56. PubMed ID: 26810324
[TBL] [Abstract][Full Text] [Related]
19. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
[TBL] [Abstract][Full Text] [Related]
20. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
